JXSS1900004 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Import Drug Application | 2019-02-25 | | | Certificate Issued | 2020-02-13 | view |
JYSB2101105 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2021-08-13 | | | | | view |
JXSB2101001 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.1) | Supplementary Application | 2021-04-01 | | | | | view |
JYSB2000352 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2020-07-30 | | | Filed | 2020-08-17 | view |
JYSB2400218 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2024-09-28 | | | | | view |
JXSL2101067 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-07-20 | | | | | view |
JXSS2101014 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-06-30 | | | | | view |
JXSB2400102 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2024-07-25 | | | | | view |
JXSL2000160 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-09-24 | | F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2020-09-23 | view |
JXSB2200011 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2022-01-25 | | | | | view |
JXSB2101002 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.1) | Supplementary Application | 2021-04-01 | | | | | view |
JYSB2400168 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2024-07-30 | | | | | view |
JXSB2101066 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-10-14 | | | | | view |
JYSZ2400037 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | License Renew | 2024-07-04 | | | | | view |
JYSB2000674 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2020-12-28 | | | Certificate Issued | 2021-03-02 | view |
JXSS2400063 | 阿替利珠单抗注射液(皮下注射) | atezolizumab | Injection | Biological Products(3.1) | Import Drug Application | 2024-07-27 | | | | | view |
JXSL2000192 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.1) | Import Drug Application | 2020-10-29 | | F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2020-10-27 | view |
JXSL2100021 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(3.1) | Import Drug Application | 2021-02-11 | | F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2021-02-11 | view |
JYSB2300128 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2023-08-10 | | | | | view |
JXSS2000033 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-09-23 | | | In Review | 2020-09-22 | view |